Parallel Health is a biotechnology company specializing in precision phage therapeutics, with a primary focus on dermatological applications and the restoration of the skin microbiome. The company leverages advanced genomic sequencing and a proprietary phage library to develop personalized solutions for chronic skin conditions. By combining diagnostic capabilities with targeted phage cocktails, Parallel Health offers an alternative to broad-spectrum antibiotics, aiming to eliminate pathogenic bacteria while preserving beneficial flora. Their vertically integrated platform enables the rapid transition from bacterial detection to custom formulation.
Parallel Health offers the following services:
- PhageSeq™ diagnostic testing – Advanced genomic sequencing to identify specific pathogenic bacterial strains present in the skin microbiome.
- Personalized phage cocktails – Formulation of custom, topical phage-based treatments designed to precisely target a patient’s unique bacterial pathogens.
- Phage library – Utilization of a diverse and continuously expanding proprietary collection of lytic bacteriophages.
Parallel Health products for Human Health
The MD-03 Protocol™ is Parallel Health’s flagship precision dermatology program, representing a comprehensive approach to skin health that moves beyond treating symptoms to address the root cause of the patient’s unique skin microbiome. The protocol integrates three core steps:
- Test – Members begin with an at-home Skin Discovery Test that uses whole genome sequencing to provide a detailed analysis of their microbial composition, including a Skin Microbiome Type™ assessment and antibiotic resistance score.
- Reset – Based on the test results, members receive a personalized Skin Health Report and a 1:1 medical consultation with a board-certified dermatologist to create a customized treatment plan.
- Rebalance – The cornerstone of the protocol is a monthly delivery of a Custom Active Phage Serum. This serum is precision-formulated with bacteriophages specifically selected to target the harmful bacteria identified on the member’s skin, effectively eliminating pathogens without disrupting the beneficial microbes essential for a healthy skin barrier.
The MD-03 Protocol™ addresses a wide range of conditions, including acne, rosacea, eczema, hidradenitis suppurativa, body odor, and signs of aging such as fine lines and loss of elasticity. Clinical results from a dermatologist-led study showed a 99.9% reduction in inflammation and blemishes. The program is structured as a membership that includes semi-annual retesting, unlimited telehealth consultations, and clinical support, and is HSA/FSA eligible.
